Serotonin 5‐HT4 receptors and their mRNAs in rat and guinea pig brain: Distribution and effects of neurotoxic lesions
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Serotonin 5‐HT 4 receptors are widely distributed in the periphery and in brain, where they modulate the release of various neurotransmitters and have been implicated in learning and memory. Nine C‐terminal splice variants of this receptor have been cloned in mammalian species. In the rat, three such variants have been described: 5‐HT 4(a), 5‐HT 4(b), and 5‐HT 4(e). In the present study, we have examined several aspects of the distribution of these receptors in brain. First, we provide, in rat and guinea pig, a detailed comparison of the distribution of 5‐HT 4 receptors labeled by the antagonist [125 I]‐SB 207710 with the distribution of their encoding mRNA visualized by in situ hybridization histochemistry (ISHH). The results suggest that, in several projection systems (striato‐nigral and striato‐pallidal pathways, projection from dentate granule cells to field CA3, habenulo‐interpeduncular pathway), 5‐HT 4 receptors are located both somatodendritically and axonally. Second, we have analyzed the distribution of mRNA for the three known rat splice variants by reverse transcription‐polymerase chain reaction (RT‐PCR) and by ISHH. RT‐PCR indicates that all three variants are widely distributed, with 5‐HT 4(b) mRNA being present in all regions examined (olfactory tubercle, striatum, hippocampus, inferior colliculus, substantia nigra, parietal cortex) and 5‐HT 4(a) and 5‐HT 4(e) showing a somewhat more restricted distribution. In other regions (periaqueductal gray, reticular formation, medial septum, diagonal band), faint ISHH signals are observed for 5‐HT 4(a)+4(e) mRNAs, whereas 5‐HT 4(b) mRNA signals are almost undetectable. Finally, neurotoxic lesions of basal ganglia components in guinea pig also indicate a location of these receptors on terminals of striatal projection neurons. J. Comp. Neurol. 484:418–439, 2005. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the significance of subterritories in the “accumbens” part of the rat ventral striatum
Zahm, D. S., & Brog, J. S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90202-d · Cited by 1,040
Cited by
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Alex, K. D., & Pehek, E. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.004 · Cited by 658
Serotonin modulation of cortical neurons and networks
Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00025 · Cited by 462
“The neocortex contains low levels of the 5-HT4 receptor and its encoding mRNA, as assessed by autoradiography and in situ hybridization, respectively (Waeber et al., 1994; Vilaró et al., 1996, 2005).”
MethodA role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory
KING, M., MARSDEN, C., & FONE, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.001 · Cited by 304
The serotonergic system and cognitive function
Švob Štrac, D., Pivac, N., & Mück-Šeler, D. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0007 · Cited by 285
Therapeutics of Neurotransmitters in Alzheimer’s Disease
Kandimalla, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161118 · Cited by 268
Reversal of hippocampal neuronal maturation by serotonergic antidepressants
Kobayashi, K., Ikeda, Y., Sakai, A., Yamasaki, N., Haneda, E., Miyakawa, T., & Suzuki, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912690107 · Cited by 212
“Because the 5-HT4 receptor is abundantly expressed in dentate GCs (39), it may play a cell-automonous role in the fluoxetineinduced GC dematuration, although it is also possible that the 5HT4 receptor indirectly contributed to the effects of fluoxetine by increasing the activity of serotonergic neurons (40).”
BackgroundHuang, Y.-Y., & Kandel, E. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3908-06.2007 · Cited by 99
“The BL of amygdala is rich in 5-HT4 receptors (Waeber et al., 1993, 1994, 1996; Jakeman et al., 1994; Eglen et al., 1995; Vilaro et al., 2005).”
BackgroundBrooker, S. M., Gobeske, K. T., Chen, J., Peng, C.-Y., & Kessler, J. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.160 · Cited by 61
Sargin, D., Jeoung, H.-S., Goodfellow, N. M., & Lambe, E. K. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00073 · Cited by 54
Noradrenaline activation of hippocampal dopamine D 1 receptors promotes antidepressant effects
Kobayashi, K., Shikano, K., Kuroiwa, M., Horikawa, M., Ito, W., Nishi, A., Segi-Nishida, E., & Suzuki, H. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117903119 · Cited by 34
Chemical Neuroanatomy of 5-HT Receptor Subtypes in the Mammalian Brain
Mengod, G., Vilaró, M. T., Cortés, R., López-Giménez, J. F., Raurich, A., & Palacios, J. M. (2006) · The Receptors · doi:10.1007/978-1-59745-080-5_10 · Cited by 33
Self-citationNasehi, M., Rostam-Nezhad, E., Ebrahimi-Ghiri, M., & Zarrindast, M.-R. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.059 · Cited by 10
Metadata
- Authors
- Vilaró, M. T., Cortés, R., & Mengod, G.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2005-03-15
- Volume
- 484
- Issue
- 4
- Pages
- 418-439
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2038333053
- Cited by
- 142
- References
- 1
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.